Xgeva and Myelodysplastic syndrome transformation - from FDA reports


There is no Myelodysplastic syndrome transformation reported by people who take Xgeva yet. This review analyzes which people have Myelodysplastic syndrome transformation with Xgeva. It is created by eHealthMe based on reports from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and find Care Guides (see testimonials).



On Sep, 23, 2018

No report is found.



Are you new to Xgeva or have questions?

On eHealthMe, Care Guides are people who "have been there". Many of them have been living or working with a drug, a condition, or both for a long time and gained substantial experience. Follow a Care Guide below to get answers between doctor visits, and guidance in everyday life.

Volunteer or get paid to help people with your care experience



Do you have Myelodysplastic syndrome transformation while taking Xgeva?



Related studies

Xgeva

Xgeva has active ingredients of denosumab. It is often used in breast cancer. (latest outcomes from Xgeva 19,402 users)

Myelodysplastic Syndrome Transformation

Myelodysplastic syndrome transformation (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged and gets changed into rapid progressing cancer) has been reported by people with myelodysplastic syndrome, preventive health care, iron overload, multiple myeloma, idiopathic thrombocytopenic purpura (latest reports from 675 Myelodysplastic syndrome transformation patients).


Drugs that are associated with Myelodysplastic syndrome transformation
Myelodysplastic syndrome transformation
Could your condition cause Myelodysplastic syndrome transformation
Myelodysplastic syndrome transformation
Xgeva side effects
Browse all side effects of Xgeva
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Xgeva and have Myelodysplastic syndrome transformation


Recent updates

General studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.